Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Put/Call Ratio
Increase
Decrease
Funds Holding
2,489
Funds Holding Change
+205
Funds Holding Growth
+9%
Value
$832B
Holding in Top 10
1,051
Top 10 Change
+46
Top 10 Growth
+5%
Value Growth
+9%
New
289
Increased
956
Reduced
1,130
Closed
55
Capital Inflow
$26.7B
Capital Outflow
$28.1B
Net Capital Flow
-$1.35B
Capital Flow Change
+$4.6B
Calls
$8.22B
Puts
$10.3B
Net Calls
-$2.1B
Put/Call Ratio
1.26